CEDAR KNOLLS, N.J.--(BUSINESS WIRE)--EKR Therapeutics, Inc., a specialty pharmaceutical company focused on acquiring, commercializing and maximizing the potential of proprietary acute-care products, today announced that its co-founder, Richard DeSimone, has been appointed to the position of Chief Operating Officer. This is a newly created position, reflecting the dramatic growth in EKR’s commercial operations in the past few months.
